Combined Approach to Stroke Thrombectomy Using a Novel Short Flexible Aspiration Catheter with a Stent Retriever : Preliminary Clinical Experience.


Journal

Clinical neuroradiology
ISSN: 1869-1447
Titre abrégé: Clin Neuroradiol
Pays: Germany
ID NLM: 101526693

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 07 04 2021
accepted: 11 05 2021
pubmed: 22 7 2021
medline: 15 6 2022
entrez: 21 7 2021
Statut: ppublish

Résumé

Large-bore aspiration catheters enabling greater flow rates and suction force for mechanical thrombectomy might improve outcomes in patients with stroke secondary to large-vessel occlusion. Complete or near-complete reperfusion after a single thrombectomy pass (first-pass effect) is associated with improved clinical outcomes. We assessed the efficacy and safety of novel MIVI Q™ aspiration catheters in combination with stent-retriever devices. We retrospectively analyzed demographics, procedure characteristics, and clinical data from consecutive patients with acute anterior large-vessel occlusion treated with a combined approach using MIVI Q™ aspiration catheters and stent retrievers. Reperfusion was defined according to the modified thrombolysis in cerebral infarction (mTICI) score. Clinical outcomes were measured by the National Institute of Health Stroke Scale (NIHSS) and modified Rankin scale (mRS) scores. We included 52 patients (median age, 75 y IQR: 64-83); 31 (59.6%) women; 14 (26.9%) with terminal internal carotid artery occlusions, 26 (50%) middle cerebral artery (MCA) segment M1 occlusions, and 12 (23.1%) MCA segment M2 occlusions; median NIHSS score at admission was 19 (IQR: 13-22). After the first pass, 25 (48%) patients had mTICI ≥ 2c. At the end of the procedure, 47 (90.4%) had mTICI ≥ 2b and 35 (67.3%) had mTICI ≥ 2c. No serious device-related adverse events were observed. Symptomatic intracranial hemorrhage developed in 1 patient. Mean NIHSS score was 13 at 24 h and 5 at discharge. At 90 days, 24 (46.2%) patients were functionally independent (mRS 0-2). This preliminary study found good efficacy and safety for MIVI Q™ aspiration catheters used in combination with stent-retriever devices.

Sections du résumé

BACKGROUND BACKGROUND
Large-bore aspiration catheters enabling greater flow rates and suction force for mechanical thrombectomy might improve outcomes in patients with stroke secondary to large-vessel occlusion. Complete or near-complete reperfusion after a single thrombectomy pass (first-pass effect) is associated with improved clinical outcomes. We assessed the efficacy and safety of novel MIVI Q™ aspiration catheters in combination with stent-retriever devices.
METHODS METHODS
We retrospectively analyzed demographics, procedure characteristics, and clinical data from consecutive patients with acute anterior large-vessel occlusion treated with a combined approach using MIVI Q™ aspiration catheters and stent retrievers. Reperfusion was defined according to the modified thrombolysis in cerebral infarction (mTICI) score. Clinical outcomes were measured by the National Institute of Health Stroke Scale (NIHSS) and modified Rankin scale (mRS) scores.
RESULTS RESULTS
We included 52 patients (median age, 75 y IQR: 64-83); 31 (59.6%) women; 14 (26.9%) with terminal internal carotid artery occlusions, 26 (50%) middle cerebral artery (MCA) segment M1 occlusions, and 12 (23.1%) MCA segment M2 occlusions; median NIHSS score at admission was 19 (IQR: 13-22). After the first pass, 25 (48%) patients had mTICI ≥ 2c. At the end of the procedure, 47 (90.4%) had mTICI ≥ 2b and 35 (67.3%) had mTICI ≥ 2c. No serious device-related adverse events were observed. Symptomatic intracranial hemorrhage developed in 1 patient. Mean NIHSS score was 13 at 24 h and 5 at discharge. At 90 days, 24 (46.2%) patients were functionally independent (mRS 0-2).
CONCLUSION CONCLUSIONS
This preliminary study found good efficacy and safety for MIVI Q™ aspiration catheters used in combination with stent-retriever devices.

Identifiants

pubmed: 34286344
doi: 10.1007/s00062-021-01065-7
pii: 10.1007/s00062-021-01065-7
pmc: PMC9187553
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

393-400

Informations de copyright

© 2021. The Author(s).

Références

Semin Intervent Radiol. 2020 Jun;37(2):119-131
pubmed: 32419724
BMC Neurol. 2019 Apr 15;19(1):65
pubmed: 30987600
Stroke. 2015 Oct;46(10):2838-42
pubmed: 26374483
Interv Neurol. 2017 Oct;6(3-4):199-206
pubmed: 29118797
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
J Neurointerv Surg. 2016 Nov;8(11):1123-1128
pubmed: 26667250
JAMA. 2017 Aug 1;318(5):443-452
pubmed: 28763550
J Neurointerv Surg. 2017 Dec;9(12):1154-1159
pubmed: 27986848
AJNR Am J Neuroradiol. 2016 Oct;37(10):1860-1865
pubmed: 27256852
Lancet. 1998 Oct 17;352(9136):1245-51
pubmed: 9788453
J Neurointerv Surg. 2021 Dec;13(12):1157-1161
pubmed: 33514612
J Neurointerv Surg. 2020 Jan;12(1):72-76
pubmed: 31273074
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
Interv Neuroradiol. 2015 Dec;21(6):707-9
pubmed: 26494404
J Neurointerv Surg. 2017 Jan;9(1):6-10
pubmed: 26984869
Stroke. 2018 May;49(5):1189-1196
pubmed: 29626134
J Neurointerv Surg. 2020 Apr;12(4):392-395
pubmed: 31473647
AJNR Am J Neuroradiol. 2018 Nov;39(11):2070-2076
pubmed: 30337435
Stroke. 2018 Mar;49(3):660-666
pubmed: 29459390
Clin Neuroradiol. 2018 Sep;28(3):327-338
pubmed: 28194477
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
Interv Neuroradiol. 2014 Jan-Feb;20(1):21-7
pubmed: 24556296
J Neurointerv Surg. 2019 Feb;11(2):190-195
pubmed: 30061368
Stroke. 2007 May;38(5):1655-711
pubmed: 17431204
N Engl J Med. 2015 Jun 11;372(24):2296-306
pubmed: 25882510
J Neurointerv Surg. 2017 May;9(5):459-462
pubmed: 27084962
J Neuroradiol. 2019 Sep;46(5):327-330
pubmed: 30981826
J Neurointerv Surg. 2018 Jun;10(6):525-529
pubmed: 28963362
J Neurointerv Surg. 2016 Mar;8(3):224-9
pubmed: 25564538
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
Clin Neuroradiol. 2019 Dec;29(4):669-676
pubmed: 30027326
J Neurointerv Surg. 2016 Jul;8(7):714-8
pubmed: 26024865
J Stroke. 2019 Jan;21(1):10-22
pubmed: 30732439
J Neurointerv Surg. 2015 Jan;7(1):2-7
pubmed: 24385554

Auteurs

Sebastian Remollo (S)

Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Interventional Neuroradiology Unit, Carretera del Canyet, s/n, 08946, Badalona, Spain. sremollo@gmail.com.

Mikel Terceño (M)

Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Interventional Neuroradiology Unit, Carretera del Canyet, s/n, 08946, Badalona, Spain.
Stroke Unit, Hospital Universitari Dr. Josep Trueta, Girona, Spain.

Mariano Werner (M)

Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Interventional Neuroradiology Unit, Carretera del Canyet, s/n, 08946, Badalona, Spain.

Carlos Castaño (C)

Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Interventional Neuroradiology Unit, Carretera del Canyet, s/n, 08946, Badalona, Spain.

María Hernández-Pérez (M)

Stroke Unit, Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Jordi Blasco (J)

Neurointerventional Department C.D.I, Hospital Clinic of Barcelona, Barcelona, Spain.

Luis San Román (L)

Neurointerventional Department C.D.I, Hospital Clinic of Barcelona, Barcelona, Spain.

Pepus Daunis-I-Estadella (P)

Department of Computer Science, Applied Mathematics and Statistics, University of Girona, Girona, Spain.

Santiago Thió-Henestrosa (S)

Department of Computer Science, Applied Mathematics and Statistics, University of Girona, Girona, Spain.

Víctor Cuba (V)

Interventional Neuroradiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.

Alfredo Gimeno (A)

Radiology Department, University Hospital of Vall d'Hebron, Barcelona, Spain.

Josep Puig (J)

IDI-Radiology, University Hospital Dr Josep Trueta, Girona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH